Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Haven, Connecticut 06519


Purpose:

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.


Criteria:

Please contact site for information.


Study is Available At:


Original ID:

NIDA-00191-2


NCT ID:

NCT00000193


Secondary ID:

K20DA000191


Study Acronym:


Brief Title:

Neurobiology of Opioid Dependence: 2 - 2


Official Title:

Neurobiology of Opioid Dependence: 2


Overall Status:

Withdrawn


Study Phase:

Phase 2


Genders:

Male


Minimum Age:

N/A


Maximum Age:

N/A


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Yale University


Oversight Authority:

United States: Federal Government


Reasons Why Stopped:


Study Type:

Interventional


Study Design:

Masking: Double-Blind, Primary Purpose: Treatment


Number of Arms:

0


Number of Groups:

0


Total Enrollment:

0


Enrollment Type:

Actual


Overall Contact Information

Official Name:Marc I Rosen, M.D.
Principal Investigator
VA Connecticut Healthcare System

Study Dates

Start Date:January 1993
Completion Date:January 1998
Completion Type:Actual
Primary Completion Date:January 1998
Primary Completion Type:Actual
Verification Date:August 2015
Last Changed Date:August 5, 2015
First Received Date:September 20, 1999

Study Outcomes

Outcome Type:Primary Outcome
Measure:Phsyiological, neuroendocrine measures of naloxone
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Behavioral, subjective, measures of naloxone-preci
Safety Issues:False

Study Interventions

Intervention Type:Drug
Name:Gamma hydroxybutyric

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Yale University
Agency Class:NIH
Agency Type:Collaborator
Agency Name:National Institute on Drug Abuse (NIDA)

Sample and Retention Information

There are no available Sample and Retention Information

Study References

Reference Type:Reference
Citation:Rosen MI, Pearsall HR, Woods SW, Kosten TR. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology. 1996 Mar;14(3):187-93.
PMID:8866702

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.